London, United Kingdom

John Francis Martin

This inventor holds 1 USPTO granted patent. Top assignee: Ucl Business Plc. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John Francis Martin. Retrieved from https://idiyas.com/inventor/john-francis-martin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of John Francis Martin

Introduction

John Francis Martin is a notable inventor based in London, GB. He has made significant contributions to the field of therapeutic applications, particularly with his innovative work involving tetrathiomolybdate. His research focuses on conditions that require reduced metabolism of an organ or the whole body, such as myocardial infarction, stroke, or ischaemia-reperfusion injury.

Latest Patents

John Francis Martin holds a patent for the therapeutic use of tetrathiomolybdate. This patent addresses the need for effective treatments in critical medical conditions, showcasing his commitment to advancing healthcare solutions. He has 1 patent to his name, reflecting his innovative approach to medical therapy.

Career Highlights

Martin is associated with UCL Business Plc, where he continues to develop and refine his ideas. His work has the potential to impact many lives, particularly those suffering from serious health conditions. His dedication to research and innovation is evident in his contributions to the medical field.

Collaborations

Throughout his career, John has collaborated with esteemed colleagues such as Mervyn Singer and Alex Peter Dyson. These partnerships have likely enriched his research and expanded the scope of his work in therapeutic applications.

Conclusion

John Francis Martin exemplifies the spirit of innovation in the medical field through his work on tetrathiomolybdate. His contributions are paving the way for new therapeutic approaches that could significantly improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…